Transplant Discharge Summary – Hospital Day 5
Date of Discharge: 2025-06-07
Attending: Dr. Jonathan R. Patel, MD
Service: Transplant Surgery

Admission Diagnosis:
End-stage renal disease, s/p deceased donor kidney transplant

Hospital Course:
- 52-year-old male admitted for kidney transplant on 2025-06-03. Underwent successful deceased donor renal transplant (KDPI 42%). Intra-op course uncomplicated.
- Post-op course notable for excellent graft function with prompt urine output. Creatinine decreased from 9.2 pre-op to 2.8 at discharge.
- Immunosuppression: Thymoglobulin x3 doses, prednisone taper, MMF, tacrolimus (goal 8–10, level at discharge 9.1).
- No evidence of infection, rejection, or surgical complication.
- Foley removed POD#3, patient voiding spontaneously.
- Pain controlled with acetaminophen and oxycodone PRN.

Discharge Medications (selected):
- Tacrolimus 3 mg PO BID
- Mycophenolate mofetil 1000 mg PO BID
- Prednisone taper: 30 mg PO daily → taper per protocol
- TMP-SMX SS daily
- Valganciclovir 450 mg daily
- Amlodipine 5 mg daily
- Insulin regimen continued

Follow-Up:
- First transplant clinic visit: 2025-06-12
- Labs twice weekly for first month (CBC, CMP, Mg, Phos, tacrolimus trough, viral PCR surveillance)
- Nurse coordinator phone call scheduled for 2025-06-10

Disposition:
Discharged home in stable condition, good graft function, excellent urine output. Patient and family received education regarding medications, warning signs (fever, decreased urine, swelling, SOB), and contact information.

Signature: _________________________
Dr. Jonathan R. Patel, MD